These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29078112)

  • 1. Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor.
    Howes TRL; Sallmyr A; Brooks R; Greco GE; Jones DE; Matsumoto Y; Tomkinson AE
    DNA Repair (Amst); 2017 Dec; 60():29-39. PubMed ID: 29078112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair.
    Chen X; Zhong S; Zhu X; Dziegielewska B; Ellenberger T; Wilson GM; MacKerell AD; Tomkinson AE
    Cancer Res; 2008 May; 68(9):3169-77. PubMed ID: 18451142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unchanged PCNA and DNMT1 dynamics during replication in DNA ligase I-deficient cells but abnormal chromatin levels of non-replicative histone H1.
    Bhandari SK; Wiest N; Sallmyr A; Du R; Ferry L; Defossez PA; Tomkinson AE
    Sci Rep; 2023 Mar; 13(1):4363. PubMed ID: 36928068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redundant but essential functions of PARP1 and PARP2 in DNA ligase I-independent DNA replication.
    Bhandari SK; Wiest N; Sallmyr A; Du R; Tomkinson AE
    Nucleic Acids Res; 2024 Sep; 52(17):10341-10354. PubMed ID: 39106163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial complementation of a DNA ligase I deficiency by DNA ligase III and its impact on cell survival and telomere stability in mammalian cells.
    Le Chalony C; Hoffschir F; Gauthier LR; Gross J; Biard DS; Boussin FD; Pennaneach V
    Cell Mol Life Sci; 2012 Sep; 69(17):2933-49. PubMed ID: 22460582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV.
    Greco GE; Matsumoto Y; Brooks RC; Lu Z; Lieber MR; Tomkinson AE
    DNA Repair (Amst); 2016 Jul; 43():18-23. PubMed ID: 27235626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel ligase I inhibitors.
    Pandey M; Kumar S; Goldsmith G; Srivastava M; Elango S; Shameem M; Bannerjee D; Choudhary B; Karki SS; Raghavan SC
    Mol Carcinog; 2017 Feb; 56(2):550-566. PubMed ID: 27312791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal germline-specific effect of DNA ligase I on CTG/CAG instability.
    Tomé S; Panigrahi GB; López Castel A; Foiry L; Melton DW; Gourdon G; Pearson CE
    Hum Mol Genet; 2011 Jun; 20(11):2131-43. PubMed ID: 21378394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of DNA ligase inhibition on the nick sealing of polβ nucleotide insertion products at the downstream steps of base excision repair pathway.
    Almohdar D; Kamble P; Basavannacharya C; Gulkis M; Calbay O; Huang S; Narayan S; Çağlayan M
    Mutagenesis; 2024 Nov; 39(6):263-279. PubMed ID: 38736258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.
    Saquib M; Ansari MI; Johnson CR; Khatoon S; Kamil Hussain M; Coop A
    Eur J Med Chem; 2019 Nov; 182():111657. PubMed ID: 31499361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered DNA ligase activity in human disease.
    Tomkinson AE; Naila T; Khattri Bhandari S
    Mutagenesis; 2020 Feb; 35(1):51-60. PubMed ID: 31630206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I.
    McNally JR; O'Brien PJ
    J Biol Chem; 2017 Sep; 292(38):15870-15879. PubMed ID: 28751376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association of DNA ligase-I polymorphism with the risk of lung cancer in north-Indian population.
    Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    DNA Cell Biol; 2006 Aug; 25(8):484-9. PubMed ID: 16907646
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Roth BM; Varney KM; Yang H; Weber DJ; Tomkinson AE
    Biomol NMR Assign; 2019 Oct; 13(2):305-308. PubMed ID: 31093909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore-based screening and identification of novel human ligase I inhibitors with potential anticancer activity.
    Krishna S; Singh DK; Meena S; Datta D; Siddiqi MI; Banerjee D
    J Chem Inf Model; 2014 Mar; 54(3):781-92. PubMed ID: 24593844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III.
    Arakawa H; Iliakis G
    Genes (Basel); 2015 Jun; 6(2):385-98. PubMed ID: 26110316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural-product inhibitors of human DNA ligase I.
    Tan GT; Lee S; Lee IS; Chen J; Leitner P; Besterman JM; Kinghorn AD; Pezzuto JM
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):993-1000. PubMed ID: 8615799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells.
    Cremaschi P; Oliverio M; Leva V; Bione S; Carriero R; Mazzucco G; Palamidessi A; Scita G; Biamonti G; Montecucco A
    PLoS One; 2015; 10(7):e0130561. PubMed ID: 26151554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
    Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
    FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human DNA ligase i (ligi) gene and risk of cervical cancer in North Indian women.
    Kaur S
    Exp Oncol; 2013 Sep; 35(3):226-8. PubMed ID: 24084463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.